Experience with the use of siltuximab in patients with SARS-CoV-2 infection

OBJECTIVES: The study aims to describe characteristics and clinical outcome of patients with SARS-CoV-2 infection that received siltuximab according to a protocol that aimed to early block the activity of IL-6 to avoid the progression of the inflammatory flare. PATIENTS AND METHODS: Retrospective re...

Descripción completa

Detalles Bibliográficos
Autores principales: Meira, Fernanda, Albiach, Laia, Carbonell, Cristina, Martín-Oterino, José-Ángel, Martín-Ordiales, Mercedes, Linares, Laura, Macaya, Irene, Agüero, Daiana, Ambrosioni, Juan, Bodro, Marta, Cardozo, Celia, Chumbita, Mariana, De la Mora, Lorena, García-Pouton, Nicole, Garcia-Vidal, Carolina, González-Cordón, Ana, Hernández-Meneses, Marta, Inciarte, Alexy, Laguno, Montserrat, Leal, Lorna, Morata, Laura, Puerta-Alcalde, Pedro, Rico, Verónica, Letona, Laura, Cózar-Llistó, Alberto, Dueñas, Gerard, Solá, Montserrat, Torres, Berta, Rojas, Jhon, Moreno, Antonio, Moreno-García, Estela, Torres, Manuel, Martínez, José A, Soriano, Alex, García, Felipe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Quimioterapia 2021
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329576/
https://www.ncbi.nlm.nih.gov/pubmed/33982984
http://dx.doi.org/10.37201/req/045.2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329576/
https://www.ncbi.nlm.nih.gov/pubmed/33982984
http://dx.doi.org/10.37201/req/045.2021

Ejemplares similares